Anaïs Glatard, Ph.D.

Senior Consultant

Portrait-of-Anais-Glatard_Pharmetheus

Bio

  • Joined Pharmetheus in 2020, actively working in client projects
  • Expertise includes clinical pharmacology and pharmacometrics in therapeutic areas such as neuroscience
  • M.Sc. in Pharmacology and modeling, Pharm.D. (2014) from University of Lyon 1, France, and Ph.D. in Life Sciences (2019) from University of Lausanne, Switzerland
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Population pharmacokinetic analysis of an octreotide depot (CAM2029) in the treatment of acromegalyExpediting MIDD evidence generation to support quizartinib approval in newly diagnosed AML patientsPopulation pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemiaPopulation pharmacokinetics of survodutide in subjects with overweight or obesity with and without Type 2 Diabetes Mellitus based on Phase I and Phase II dataPopulation Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)